2018
DOI: 10.1016/j.neuron.2018.01.017
|View full text |Cite
|
Sign up to set email alerts
|

A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia

Abstract: SUMMARY Parkinson’s disease is characterized by the progressive loss of midbrain dopamine neurons. Dopamine replacement therapy with levodopa alleviates parkinsonian motor symptoms but is complicated by the development of involuntary movements, termed levodopa-induced dyskinesia (LID). Aberrant activity in the striatum has been hypothesized to cause LID. Here, to establish a direct link between striatal activity and dyskinesia, we combine optogenetics and a method to manipulate dyskinesia-associated neurons, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
96
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(104 citation statements)
references
References 43 publications
(51 reference statements)
8
96
0
Order By: Relevance
“…Our findings reveal transcriptional distinctions that demarcate PF cell-type classes and also separate it from its neighboring medial dorsal nucleus in the anterior-posterior axis and the posterior nucleus in medial-lateral axis. Thus, these results permit targeted analyses of specific PF subcircuits and neuron classes in normal behavior and disease-models, similar to studies already underway in other brain regions(Svoboda and Li, 2018) (Beyeler et al, 2018) (Wallace et al, 2017) (Saunders et al, 2015) (Girasole et al, 2018) (Mastro et al, 2014) but not previously possible in the ILM of the TH.…”
supporting
confidence: 63%
“…Our findings reveal transcriptional distinctions that demarcate PF cell-type classes and also separate it from its neighboring medial dorsal nucleus in the anterior-posterior axis and the posterior nucleus in medial-lateral axis. Thus, these results permit targeted analyses of specific PF subcircuits and neuron classes in normal behavior and disease-models, similar to studies already underway in other brain regions(Svoboda and Li, 2018) (Beyeler et al, 2018) (Wallace et al, 2017) (Saunders et al, 2015) (Girasole et al, 2018) (Mastro et al, 2014) but not previously possible in the ILM of the TH.…”
supporting
confidence: 63%
“…For instance, Alcacer et al () found dyskinesia scores resembling those observed in LID when chemogenetic activation of dMSN was combined with a D 2 receptor agonist, suggesting that inhibition of iMSN by D 2 receptors is necessary for full expression of LID. Furthermore, a genetic model allowing to “trap” active neurons during LID recruited mainly dMSN but also iMSN (Girasole et al, ), and recent studies show modulations of activity in both dMSN and iMSN during LID (Parker et al, ; Ryan et al, ). However, optostimulation of striatonigral axon terminals can cause more powerful dyskinesia than moderate and even high doses of L‐DOPA, which cannot be further increased by combining optostimulation with L‐DOPA.…”
Section: Discussionmentioning
confidence: 99%
“…These and other data (Bateup et al 2010; Fasano et al 2010; Heiman et al 2014; Suarez et al 2018, 2016) indicate that changes in dSPN activity driven by concomitant strong activation of ERK1/2 and cAMP/PKA signaling are key to the emergence of involuntary movements. Further implicating the critical role of direct pathway overactivity in LID, a recent study has reported that a stable group of dSPNs in the dorsolateral striatum are very active during the expression of dyskinesia, and that optogenetically inhibiting these neurons significantly reduces the severity of LID (Girasole et al 2018). Notwithstanding the pivotal role of the direct pathway, LID involves pronounced synaptic remodelling of iSPNs (Fieblinger et al 2014; Suarez et al 2014, 2018, 2016) and it is improved by chemogenetic stimulation of these neurons (Alcacer et al 2017).…”
Section: The Striatummentioning
confidence: 99%